An update on nonhuman primate usage for drug and vaccine evaluation against filoviruses

Marc-Antoine de La Vega,Ara XIII,Christopher S. Massey,Jessica R. Spengler,Gary P. Kobinger,Courtney B. Woolsey
DOI: https://doi.org/10.1080/17460441.2024.2386100
2024-08-20
Expert Opinion on Drug Discovery
Abstract:Introduction Due to their faithful recapitulation of human disease, nonhuman primates (NHPs) are considered the gold standard for evaluating drugs against Ebolavirus and other filoviruses. The long-term goal is to reduce the reliance on NHPs with more ethical alternatives. In silico simulations and organoid models have the potential to revolutionize drug testing by providing accurate, human-based systems that mimic disease processes and drug responses without the ethical concerns associated with animal testing. However, as these emerging technologies are still in their developmental infancy, NHP models are presently needed for late-stage evaluation of filovirus vaccines and drugs, as they provide critical insights into the efficacy and safety of new medical countermeasures.
pharmacology & pharmacy
What problem does this paper attempt to address?